Persontilpasset medisin for kardiovaskulær, metabolsk og nyresykdom (CARMEN2026)

This call from the European Partnership for Personalised Medicine (EP PerMed) will fund research projects on innovative precision medicine strategies for patients with cardiovascular disease, metabolic diseases, or kidney diseases. Research projects can focus on a single disease or across these conditions. Applications should address one or more of the following aspects: innovative, personalized therapeutic approaches; monitoring treatment response in patients to tailor treatment pathways; early prediction of disease risk and prevention of deterioration or comorbidities. This is an international joint call with participation from multiple countries. The Research Council of Norway is participating with 1.5 million Euro. The total call budget is approximately 38 million Euro.